These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39205505)

  • 1. New clinical approach in facial mild-moderate acne: Re-stabilization of skin microbiota balance with a topical biotechnological phytocomplex.
    De Lucas R; Martínez H; Nieto C; Ruiz-Alonso C; Bermejo R; Carrón N; Garcia-Segura S; Gonzalez-Torres P; Palacios-Martínez D; Guerra-Tapia A; Bou L; Pérez M
    J Cosmet Dermatol; 2024 Nov; 23(11):3616-3627. PubMed ID: 39205505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new topical biotechnological phytocomplex for truncal mild-moderate acne restores skin microbiota balance.
    Guerra-Tapia A; Martínez H; Nieto C; Ruiz Alonso C; Bermejo R; Carrón N; Garcia-Segura S; Gonzalez-Torres P; Palacios-Martínez D; Bou L; Pérez M; De Lucas R
    Skin Res Technol; 2024 Jul; 30(7):e13806. PubMed ID: 39044362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ceramides and niacinamide-containing moisturizer versus hydrophilic cream in combination with topical anti-acne treatment in mild to moderate acne vulgaris: A split face, double-blinded, randomized controlled trial.
    Tempark T; Shem A; Lueangarun S
    J Cosmet Dermatol; 2024 May; 23(5):1758-1765. PubMed ID: 38299457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Systemic Antibiotic Treatment of Acne With Skin Microbiota Characteristics.
    Chien AL; Tsai J; Leung S; Mongodin EF; Nelson AM; Kang S; Garza LA
    JAMA Dermatol; 2019 Apr; 155(4):425-434. PubMed ID: 30758497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phase 2b, Randomized, Double-Blind Vehicle Controlled, Dose Escalation Study Evaluating Clascoterone 0.1%, 0.5%, and 1% Topical Cream in Subjects With Facial Acne.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):570. PubMed ID: 31251550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Clinical Study Evaluating the Efficacy of Topical Bakuchiol (UP256) Cream on Facial Acne.
    Brownell L; Geen S; E Y; Lee WL
    J Drugs Dermatol; 2021 Mar; 20(3):307-310. PubMed ID: 33683079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isotretinoin and lymecycline treatments modify the skin microbiota in acne.
    Kelhälä HL; Aho VTE; Fyhrquist N; Pereira PAB; Kubin ME; Paulin L; Palatsi R; Auvinen P; Tasanen K; Lauerma A
    Exp Dermatol; 2018 Jan; 27(1):30-36. PubMed ID: 28636791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
    Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
    Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
    Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
    J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
    Hebert A; Thiboutot D; Stein Gold L; Cartwright M; Gerloni M; Fragasso E; Mazzetti A
    JAMA Dermatol; 2020 Jun; 156(6):621-630. PubMed ID: 32320027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical Minocycline Foam 4%: A Review in Acne Vulgaris.
    Paik J
    Am J Clin Dermatol; 2020 Jun; 21(3):449-456. PubMed ID: 32468355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical aminolaevulinic acid-photodynamic therapy for the treatment of acne vulgaris: a study of clinical efficacy and mechanism of action.
    Pollock B; Turner D; Stringer MR; Bojar RA; Goulden V; Stables GI; Cunliffe WJ
    Br J Dermatol; 2004 Sep; 151(3):616-22. PubMed ID: 15377348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne.
    Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S
    Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
    Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
    Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic Profile, Safety, and Tolerability of Clascoterone (Cortexolone 17-alpha propionate, CB-03-01) Topical Cream, 1% in Subjects With Acne Vulgaris: An Open-Label Phase 2a Study.
    Mazzetti A; Moro L; Gerloni M; Cartwright M
    J Drugs Dermatol; 2019 Jun; 18(6):563. PubMed ID: 31251549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Comparison of Topical 2.5% Benzoyl Peroxide plus 5% Niacinamide to 2.5% Benzoyl Peroxide Alone in the Treatment of Mild to Moderate Facial Acne Vulgaris.
    Kaewsanit T; Chakkavittumrong P; Waranuch N
    J Clin Aesthet Dermatol; 2021 Jun; 14(6):35-41. PubMed ID: 34804354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ; Holland KT; Bojar R; Levy SF
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Tretinoin 0.05% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in a Hispanic Population.
    Cook-Bolden FE; Weinkle SH; Guenin E; Bhatt V
    J Drugs Dermatol; 2019 Jan; 18(1):32-38. PubMed ID: 30681791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Intense Pulsed Light on the Skin Microbiota and Epidermal Barrier in Patients with Mild to Moderate Acne Vulgaris.
    Liu J; Liu L; Zhou L; Chen L; Chen X; Xiong X; Deng Y
    Lasers Surg Med; 2021 Dec; 53(10):1348-1355. PubMed ID: 34224604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Topically Applied Selected Cutibacterium acnes Strains over Five Weeks in Patients with Acne Vulgaris: An Open-label, Pilot Study.
    Karoglan A; Paetzold B; Pereira de Lima J; Brüggemann H; Tüting T; Schanze D; Güell M; Gollnick H
    Acta Derm Venereol; 2019 Dec; 99(13):1253-1257. PubMed ID: 31573666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.